EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Trigeminal Neuralgia in Multiple Sclerosis: A Critical Review of the Therapeutic Evidence and the Role of Cerebellopontine Angle Surgical Exploration

Luis Ley Urzaiz iD, Rodrigo Carrasco Moro iD

Brain Sciences · 19.08.2026 · 16 (8) · 881

DOI: 10.3390/brainsci16080881 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Brain Sciences, online erschienen am 19.08.2026. Verfasst von Luis Ley Urzaiz und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, Hospital Universitario Ramón y Cajal, 28034 Madrid, Spain. Die Arbeit nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Trigeminal neuralgia associated with multiple sclerosis (TN-MS) is a secondary facial pain syndrome whose clinical and therapeutic features differ substantially from those of classical TN. Although the literature comparing treatment outcomes between TN-MS and classical TN is relatively abundant, evidence on the impact of treatment on quality of life in TN-MS is scarce. In patients with MS—already vulnerable owing to the course of their disease and the burden of its treatments—therapeutic success cannot be defined by pain scales alone, because even modest analgesic improvement and, in particular, a reduction in medication burden may represent meaningful gains. This review aims to reappraise the therapeutic goals in TN-MS.

Methods

We provide a critical narrative review of the evidence, explicitly distinguishing direct evidence from indirect evidence extrapolated from the MS and classical-TN literature, across medical therapy, percutaneous procedures, stereotactic radiosurgery, and microvascular decompression (MVD).

Results

First-line pharmacotherapy remains standard but is largely extrapolated from classical TN, and tolerability is frequently limited by sedative and motor adverse effects in already polymedicated patients. Percutaneous procedures and radiosurgery provide clinically meaningful relief in selected patients, but recurrence is common and patient-centered outcomes are poorly documented. Surgical exploration of the cerebellopontine angle—including MVD, neurolysis, and combined techniques—should not be categorically excluded on the basis of an MS diagnosis in carefully selected patients, although outcomes are generally less favorable than in classical TN and the direct evidence is limited and vulnerable to selection bias.

Conclusions

Future studies should assess treatment impact on additional outcomes such as medication burden, quality of life, fatigue, cognition, and functional status.

Schlagwörter

Stichwörter der Autor:innen

cerebellopontine anglehealth-related quality of lifemedication burdenmicrovascular decompressionmultiple sclerosisneurolysispatient-centered outcomesstereotactic radiosurgerysurgical explorationtrigeminal neuralgia

Autor:innen und Institutionen

  • Department of Neurosurgery, Hospital Universitario Ramón y Cajal, 28034 Madrid, Spain.

ORCID-Profile: Luis Ley Urzaiz, Rodrigo Carrasco Moro

Zitieren

APA

Ley Urzaiz, L., & Carrasco Moro, R. (2026). Trigeminal Neuralgia in Multiple Sclerosis: A Critical Review of the Therapeutic Evidence and the Role of Cerebellopontine Angle Surgical Exploration. Brain Sciences, 16(8), 881. https://doi.org/10.3390/brainsci16080881

Vancouver

Ley Urzaiz L, Carrasco Moro R. Trigeminal Neuralgia in Multiple Sclerosis: A Critical Review of the Therapeutic Evidence and the Role of Cerebellopontine Angle Surgical Exploration. Brain Sciences. 2026;16(8):881. doi:10.3390/brainsci16080881

BibTeX
@article{LeyUrzaiz2026,
  author = {Ley Urzaiz, Luis and Carrasco Moro, Rodrigo},
  title = {Trigeminal Neuralgia in Multiple Sclerosis: A Critical Review of the Therapeutic Evidence and the Role of Cerebellopontine Angle Surgical Exploration},
  journal = {Brain Sciences},
  year = {2026},
  volume = {16},
  number = {8},
  pages = {881},
  doi = {10.3390/brainsci16080881}
}
Kostenlos starten →